Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders.
Dynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis.
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.
The association between functional HLA-G 14 bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis.
Decrease in rate of multiple sclerosis-related hospitalizations in Portugal.
Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.
Global gene expression profiles in brain regions reflecting abnormal neuronal and glial functions targeting myelin sheaths after 28-day exposure to cuprizone in rats.
Microglia: Senescence Impairs Clearance of Myelin Debris.
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions.
Inflammatory demyelinating neuropathy heralding accelerated Chediak-Higashi syndrome.
[Anti-NMDA Receptor Antibody-Related Encephalitis].
The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary.
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.
Self-reported levels of education and disability progression in multiple sclerosis.
The Gas6/TAM System and Multiple Sclerosis.
Incidence and Natural History of Idiopathic Chronic Inflammatory Demyelinating Polyneuropathy: A Population-Based Study in Iceland.
Critical Appraisal of Evidence for Improving Gait Speed in People with Multiple Sclerosis: Dalfampridine Versus Gait Training.
Isolated pure verbal amnesia as the disease onset of probable multiple sclerosis with a left forniceal black hole.
Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide.
Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis.
Influenza vaccination in patients with multiple sclerosis is possible with some considerations.
Antibody-Mediated Autoimmune Encephalitis in Childhood.
Spasticity in multiple sclerosis and role of glatiramer acetate treatment.
Pages
« first
‹ previous
…
831
832
833
834
835
836
837
838
839
…
next ›
last »